Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Therapy in Rectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT06300489
What this trial is testing

Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Zhejiang Cancer Hospital 30
Testing effectiveness (Phase 2)UnknownNCT02688023
What this trial is testing

Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer

Who this might be right for
Colorectal Cancer
Chinese Academy of Medical Sciences 50
Early research (Phase 1)Study completedNCT02754856
What this trial is testing

Tremelimumab and Durvalumab in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery

Who this might be right for
Metastatic Carcinoma in the LiverResectable MassStage IV Colorectal Cancer AJCC v7+2 more
M.D. Anderson Cancer Center 24
Large-scale testing (Phase 3)UnknownNCT03177382
What this trial is testing

Total Neoadjuvant Treatment vs. Chemoradiotherapy in Local Advanced Rectal Cancer With High Risk Factors

Who this might be right for
Total Neoadjuvant TreatmentChemoradiotherapyLocal Advanced Rectal Cancer+1 more
West China Hospital 458
Large-scale testing (Phase 3)Ended earlyNCT03158610
What this trial is testing

Biological-guided Metronomic Chemotherapy as Maintenance Strategy in Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Ruijin Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT07595874
What this trial is testing

Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3

Who this might be right for
Advanced Colon AdenocarcinomaAdvanced Colorectal AdenocarcinomaAdvanced Rectal Adenocarcinoma+10 more
City of Hope Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT04009876
What this trial is testing

Evaluate a Chemotherapy Treatment Followed by Chemo and Radiotherapy in Patients With Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)
Fundación de investigación HM 30
Not applicableStudy completedNCT01914068
What this trial is testing

The Effects of a 9 Week Exercise Programme on Fitness and Quality of Life in Rectal Cancer Patients After Chemoradiotherapy and Before Surgery

Who this might be right for
Rectal Cancer
University Hospital Southampton NHS Foundation Trust 34
Not applicableStudy completedNCT06898359
What this trial is testing

Role of Gut Microbiota in Neoadjuvant Radioimmunotherapy for MSS, Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Yanhong Deng 29
Large-scale testing (Phase 3)UnknownNCT01064999
What this trial is testing

A Trial of High Intensity Versus Low Intensity Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Fudan University 240
Testing effectiveness (Phase 2)UnknownNCT00689702
What this trial is testing

Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal Cancer

Who this might be right for
Rectal Cancer
Institute of Oncology Ljubljana 43
Large-scale testing (Phase 3)UnknownNCT05081687
What this trial is testing

Brazilian Total Neoadjuvant Therapy Trial

Who this might be right for
Colorectal Neoplasms
Hospital Israelita Albert Einstein 150
Testing effectiveness (Phase 2)Study completedNCT04864067
What this trial is testing

No Operation After Short Course Radiotherapy Followed By Consolidation Chemotherapy In Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Servicio de Salud Metropolitano Sur Oriente 39
Testing effectiveness (Phase 2)UnknownNCT02591667
What this trial is testing

Histopathological Response to FOLFOXIRI + Bevacizumab in Peritoneal Metastasis From Colorectal Cancer

Who this might be right for
Colorectal CancerPeritoneal Metastasis
Medical University of Vienna 30
Early research (Phase 1)Ended earlyNCT05446129
What this trial is testing

A Study in People With Colorectal Cancer to Test Whether Ezabenlimab or Pembrolizumab in Combination With BI 765063 Lead to Side Effects or Delays in Surgery

Who this might be right for
Colorectal Cancer
Boehringer Ingelheim 2
Large-scale testing (Phase 3)Looking for participantsNCT07505472
What this trial is testing

Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Without Concurrent Surufatinib in Neoadjuvant Therapy for Mid-to-low Localized Rectal Cancer of High-risk Criteria

Who this might be right for
Rectal Cancer
The First Hospital of Jilin University 212
Testing effectiveness (Phase 2)Looking for participantsNCT07561060
What this trial is testing

Low Rectal Cancer Treated With Total Neoadjuvant Therapy Plus Concurrent Tislelizumab Immunotherapy

Who this might be right for
Rectal Cancer
Fudan University 50
Not applicableLooking for participantsNCT03064646
What this trial is testing

Organ Preservation in Locally Advanced Rectal Cancer

Who this might be right for
LOCALLY ADVANCED RECTAL CANCER
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT06832917
What this trial is testing

Short-course Radiation (SCRT) Followed by 6 Cycles of Cadonilimab Plus MFOLFOX6 As Neoadjuvant Therapy for Patients with Locally Advanced Rectal Cancer (LARC): a Multicenter, Two-arm Parallel, Open-label, Randomised Phase III Trial (NeoCaCRT-III)

Who this might be right for
Rectal Cancer
Wan He 238
Testing effectiveness (Phase 2)Active Not RecruitingNCT04017455
What this trial is testing

Neoadjuvant Treatment in Rectal Cancer With Radiotherapy Followed by Atezolizumab and Bevacizumab (TARZAN)

Who this might be right for
Rectal Cancer
The Netherlands Cancer Institute 38
Next Page